Related Experiment Video
Updated: Jul 11, 2026
09:32
Polycrystalline Silicon Thin-film Solar cells with Plasmonic-enhanced Light-trapping
Published on: July 2, 2012
19.4K
Bio-inspired Plasmonic Nanoarchitectured Hybrid System Towards Enhanced Far Red-to-Near Infrared Solar Photocatalysis
Runyu Yan1, Min Chen1, Han Zhou1
1State Key Lab of Metal Matrix Composites, Department of Materials Science and Engineering, Shanghai Jiaotong University, Shanghai, 200240, China.
Scientific Reports
|January 29, 2016
Summary
This study introduces a novel biomimetic approach for enhanced solar energy conversion using near-infrared (NIR) light. By mimicking butterfly wing structures, researchers boosted NIR light harvesting and photocatalysis efficiency.
Area of Science:
- Materials Science
- Photocatalysis
- Renewable Energy
Background:
- Near-infrared (NIR) light constitutes a significant portion of solar energy (approx. 40%) but is underutilized in solar conversion technologies.
- Developing efficient strategies for capturing and utilizing NIR light for photocatalysis remains a key challenge.
- Nature's sophisticated micro/nanoarchitectures offer inspiration for advanced light-harvesting systems.
Purpose of the Study:
- To develop a novel biomimetic photocatalytic system for efficient solar energy conversion using far red-to-near infrared (NIR) light.
- To investigate the enhancement of photocatalytic activity by integrating light-harvesting plasmonic nanoantennas with bio-inspired 3D micro/nanoarchitectures.
- To elucidate the underlying mechanisms responsible for improved NIR photocatalysis.
Main Methods:
- Fabrication of a photocatalytic system by assembling plasmonic nanoantennas onto butterfly wing-inspired 3D micro/nanoarchitectures.
- Utilizing experiments and finite-difference time-domain (FDTD) simulations to analyze structural effects on photocatalysis.
- Quantifying NIR light harvesting enhancement and localized surface plasmon (LSP) electric-field amplitude.
Main Results:
- Demonstrated significant enhancement in far red-to-NIR (700–1200 nm) photocatalysis.
- Achieved up to a 25% increase in NIR light harvesting.
- Observed over a 3.5-fold enhancement in localized surface plasmon (LSP) electric-field amplitude, boosting electron-hole pair generation.
Conclusions:
- The bio-inspired design effectively enhances NIR photocatalysis by improving light harvesting and plasmonic field enhancement.
- This study presents a new methodology for NIR photocatalysis, leveraging nature's architectural strategies.
- The findings provide a foundation for designing next-generation NIR-responsive photocatalytic systems.
Related Concept Videos
01:28Structure-Activity Relationships and Drug Design
Drug design is a dynamic field that involves discovering and developing new medications based on specific biological targets. This process heavily relies on structure-activity relationships (SAR) and quantitative structure-activity relationships (QSAR) to guide the design and optimization of efficient drugs.
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence its...
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence its...
01:17Oral Hypoglycemic Agents: Sulfonylureas
Sulfonylureas are oral hypoglycemic agents utilized in treating type 2 diabetes. They are characterized by their unique sulfonylurea chemical structure. The family of sulfonylureas is divided into generations. First-generation sulfonylureas, including tolbutamide (Orinase), chlorpropamide (Diabinese), and tolazamide (Tolinase), trigger insulin release from pancreatic β cells and enhance peripheral tissues' insulin sensitivity. The second-generation members, such as glipizide (Glucotrol),...
01:24Glucagon-like Receptor Agonists
Incretins include glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP), which stimulate insulin secretion post-meals. In type 2 diabetes, GIP's efficacy is reduced, making GLP-1 a viable drug target. GIP originates from preproGIP.
GLP-1, when administered in high doses intravenously, triggers insulin secretion, inhibits glucagon release, slows gastric emptying, reduces food intake, and restores normal insulin secretion. However, its rapid inactivation by the...
GLP-1, when administered in high doses intravenously, triggers insulin secretion, inhibits glucagon release, slows gastric emptying, reduces food intake, and restores normal insulin secretion. However, its rapid inactivation by the...